TIGIT and neoplasm: The gene expression analysis on these cells showed that the TIGIT, an immune checkpoint gene participating in the tumor immune escape, was highly and specifically expressed in Treg cells and proliferating Treg cells, and TIGIT showed differential expression in Treg cells between drug-resistant patients and drug-sensitive ones (Fig. 4d, e) [33, 34].